A Safety and Efficacy Study of Tavilermide (MIM-D3) Ophthalmic Solution for the Treatment of Dry Eye
Clinical trial NCT02634853 · COMPLETED
Trial details
- NCT number
- NCT02634853
- Sponsor
- Mimetogen Pharmaceuticals USA, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2015-12-01
- Primary completion
- 2017-02-01
- Enrollment
- 429
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.